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Abstract
Background: The mechanisms by which partial liquid ventilation (PLV) can improve gas
exchange in acute lung injury are still unclear. Therefore, we examined the time- and dose-
dependency of the improvements in arterial oxygen tension (PaO2) due to PLV in eight pigs
with experimental lung injury, in order to discriminate increases due to oxygen dissolved in
perfluorocarbon before its intrapulmonary instillation from a persistent diffusion of the
respiratory gas through the liquid column.
Results: Application of four sequential doses of perfluorocarbon resulted in a dose-
dependent increase in PaO2. Comparison of measurements 5 and 30min after instillation of
each dose revealed a time-dependent decrease in PaO2 for doses that approximated the
functional residual capacity of the animals.
Conclusion: Although oxygen dissolved in perfluorocarbon at the onset of PLV can cause a
short-term improvement in arterial oxygenation, diffusion of oxygen through the liquid may not
be sufficient to maintain the initially observed increase in PaO2.
Keywords: acute lung injury, partial liquid ventilation, perfluorocarbon
Received: 30 March 1999
Revisions requested: 9 August 1999
Revisions received: 15 November 1999
Accepted: 2 December 1999
Published: 10 February 2000
Crit Care 2000, 4:114–119
The electronic version of this article can be found online at
http://ccforum.com/content/4/2/114
© Current Science Ltd
ALI = acute lung injury; ARDS = acute respiratory distress syndrome; CaO2 = arterial oxygen content; CcO2 = pulmonary capillary oxygen content;
CvO2 = mixed venous oxygen content; PaO2 = arterial oxygen tension; PEEP = positive end-expiratory pressure; PLV = partial liquid ventilation.
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Introduction
Partial liquid ventilation (PLV) is a novel technique to
improve gas exchange in acute lung injury (ALI). It combines
the intrapulmonary application of perfluorocarbons in
volumes up to the functional residual capacity of the lungs
with conventional gaseous ventilation [1], and has been
shown to improve gas exchange and lung mechanics in a
dose-dependent manner in experimental and clinical set-
tings of severe respiratory failure [2–5]. Two different mech-
anisms are presently proposed to account for a persistent
increase in arterial oxygenation during PLV. First, it is sug-
gested that the low surface tension of perfluorocarbons
(10–15dyn/cm) can facilitate the recruitment of atelectatic
lung segments for ventilation, indicated by an increase in
lung compliance [6]. Second, it is hypothesized that pooling
of the dense compounds (1.75–1.92g/ml) along the gravi-
tational gradient causes a redistribution of pulmonary blood
flow from dependent to nondependent, better ventilated
lung areas, due to a compression of the pulmonary vascula-
ture in the dorsal lung regions [7,8]. Additionally, the high
solubility of oxygen and carbon dioxide in perfluorocarbons
(40–60 and 160–210ml/100ml, respectively) suggests a
potential role for these substances as transport media for
the respiratory gases in nonventilated but perfluorocarbon-http://ccforum.com/content/4/2/114
filled, dependent lung segments, depending on the diffu-
sion of oxygen and carbon dioxide through the liquid. A
persistent effect on pulmonary gas exchange requires an
efficient transfer of oxygen from the inspired gas to the
perfluorocarbon and through the liquid column to the
alveoli. Oxygen dissolved in perfluorocarbon before the
intrapulmonary instillation of the compound, however, may
cause only a short-lasting improvement in arterial oxygena-
tion after the onset of PLV.
The aim of this study was to discriminate such diffusion-
dependent short-term and long-term effects of PLV on arte-
rial oxygenation by testing the time-dependency of
increases in arterial oxygen tension (PaO2) during PLV with
four different doses of perfluorocarbon in an experimental
model of ALI in medium sized pigs. We found a time- and
dose-dependent increase in PaO2 in this setting, suggest-
ing a minor role of oxygen transfer through perfluorocarbon
in the improvement of gas exchange observed during PLV.
Materials and methods
Animal preparation
The experimental protocol was approved by the appropri-
ate governmental institution and the study was performed
according to the Helsinki convention for the use and care
of animals.
In eight female pigs (27±5 kg body weight), anaesthesia
was induced with metomidate (2mg/kg) and maintained
with the continuous infusion of methohexital (50–100mg/kg
per min) and sufentanil (25–50ng/kg per min). Muscle relax-
ation was achieved with pancuronium bromide (3mg/kg per
min). All animals were positioned supine and a tracheotomy
and subsequent intubation with a 8.0–9.0mm inner diame-
ter endotracheal tube were performed. Volume-controlled
ventilation was instituted using a respirator (Servo 900 C;
Siemens Elema, Lund, Sweden) with a fraction of inspired
oxygen of 1.0, a respiratory rate of 20breaths/min, a mean
tidal volume of 10ml/kg, a positive end-expiratory pressure
(PEEP) of 5cmH2O and an inspiration:expiration ratio of
1:2 without pause time. The ventilator setting remained
unchanged during the study.
A 18 G arterial line (Vygon, Ecouen, France) and a 8.5Fr
venous sheath (Arrow Deutschland GmbH, Erding,
Germany) for positioning of a right heart catheter (model
93A-431-7.5 F; Baxter Healthcare Corporation, Irvine, CA,
USA) under transduced pressure guidance were percuta-
neously inserted into the femoral vessels.
The blood temperature, determined by means of the pul-
monary artery catheter, was maintained at 37.2±1.1°C
during the experiment using an infrared warming lamp and
a warming pad. A continuous infusion of 4–5ml/kg per min
of a balanced electrolyte solution was administered for
adequate hydration.
Data acquisition
All haemodynamic measurements were taken in the supine
position with zero reference level at the midchest. Central
venous pressure, mean arterial pressure, mean pulmonary
arterial pressure and pulmonary artery occlusion pressure
of all animals were transduced (Baxter Deutschland
GmbH, Unterschleißheim, Germany) and recorded
(Hewlett-Packard Model 66 S monitor; Böblingen,
Germany). Cardiac output was determined using standard
thermodilution techniques (Baxter Deutschland GmbH)
and expressed as the mean of three measurements at
end-expiration of different respiratory cycles. Heart rate
was taken from the blood pressure curve.
Arterial and mixed venous blood samples were collected
anaerobically and immediately analyzed for partial oxygen
tension, partial carbon dioxide tension and pH using stan-
dard blood gas electrodes (ABL 520; Radiometer, Copen-
hagen, Denmark). Species-specific spectrophotometry
was performed to obtain arterial and mixed venous oxygen
saturation and total haemoglobin concentration (OSM 3
Hemoximeter; Radiometer).
The oxygen contents (ml/dl) of arterial (CaO2), mixed
venous (CvO2) and pulmonary capillary (CcO2) samples
were calculated using the following formula: content of
oxygen = (haemoglobin concentration × 1.34 × percent-
age oxygen saturation/100) + (partial oxygen tension ×
0.0031). To calculate CcO2, the pulmonary capillary
oxygen tension was assumed to be equivalent to the alve-
olar partial oxygen tension, which was estimated as
follows: barometric pressure – arterial carbon dioxide
tension/respiratory quotient (assuming that the respiratory
quotient is 0.8) – water vapour pressure (47mmHg) – per-
fluorocarbon vapour pressure [61mmHg for FC 3280 (3M
Chemical Products, Neuss, Germany), only when PLV was
performed] [9]. The venous admixture was derived from
the standard shunt equation: (CcO2 – CaO2)/(CcO2 –
CvO2).
Experimental protocol
ALI was induced in all animals according to the method of
Lachmann et al [10] by surfactant depletion caused by
repeated lung lavage with prewarmed saline (0.15mol/l,
37°C, 30ml/kg). Baseline values for ALI were collected
after the PaO2 remained persistently below 100 mmHg for
1h without further interventions. Subsequently, four incre-
mental doses of 7.5ml/kg FC 3280 (3M Chemical Prod-
ucts) were intratracheally administered via a swivel-
connector (Portex, Kent, UK) without disconnecting the
animals from the respirator or interrupting ventilation. Each
dose was administered in volumes of 2–2.5ml perfluoro-
carbon per inspiration, requiring approximately 4min until
the total volume of 7.5ml/kg was applied. To compensate
for losses due to evaporation, a volume of 4ml/kg per h of
FC 3280 was continuously administered endotracheallyCritical Care    Vol 4 No 2 Max et al
when PLV was performed [11]. FC 3280 (C8F18) is a
highly purified industrial perfluorocarbon with physical and
chemical properties comparable to those of perflubron
(LiquiVent; Alliance, San Diego, USA), which is at present
the most commonly used perfluorocarbon in experimental
and clinical settings of PLV, but which is not available in
Europe. The density of FC 3280 is 1.75 g/cm3, it has a
viscosity of 0.7 centistokes, a vapour pressure of 61 torr
and a surface tension of 12mN/m at 25°C, and it can dis-
solve up to 40ml oxygen/100ml perfluorocarbon and
192ml carbon dioxide/100ml perfluorocarbon.
All haemodynamic and gas exchange parameters were
determined 5 and 30min after starting the instillation of
each dose of perfluorocarbon. At the end of the study, all
animals were killed with an intravenous application of
potassium chloride.
Statistical analyses
All data are expressed as means ± standard deviation.
Statistical analyses were performed using the NCSS 6.0.7
software package (NCSS, Kaysville, USA). The data were
analyzed by analysis of variance for repeated measure-
ments, followed by Bonferroni’s multiple comparison test
when analysis of variance revealed significant differences
for all treatment periods. P<0.05 was considered statisti-
cally significant.
Results
All animals survived the entire study period. Examination of
all animals by a veterinary surgeon before the study con-
firmed the absence of any sign of infection or pulmonary
disease. Total haemoglobin concentration and capillary
oxygen content remained unchanged throughout the study.
A mean of 8±2 lavages had to be performed in order to
obtain a stable ALI, with a persistent decrease in PaO2
from 542±32 to 48±11mmHg.
Gas exchange
Partial liquid ventilation resulted in a dose-dependent
increase of arterial oxygenation, which reached statistical
significance compared to ALI when PaO2 was measured
5min after the onset of PLV with 15, 22.5 and 30ml/kg
perfluorocarbon, respectively (P<0.001). Determination
of the PaO2 after 30min revealed a persistent improve-
ment in PaO2 compared with values after inducing lung
injury, when PLV was performed with 22.5 and 30ml/kg
FC 3280 (P<0.001). A significant decrease in arterial
oxygenation was observed with the latter doses when
values after 5min were compared with measurements
obtained after 30min, however (P<0.001; Fig. 1). The
venous admixture decreased after the instillation of perflu-
orocarbon doses of 15ml/kg or greater when compared
with ALI, with no differences between measurements after
5 and 30min for each dose (Table 1). PaCO2 increased
from 39±7 to 48±6mmHg (P < 0.001) with a concomi-
tant decrease in pH from 7.48±0.08 to 7.37±0.06
(P<0.001) after the induction of lung injury and remained
stable thereafter throughout the study (Table 2).
Haemodynamics
All haemodynamic data are summarized in Table 3. No
changes for mean arterial pressure, central venous pres-
sure, pulmonary artery occlusion pressure, heart rate and
cardiac output were observed throughout the entire study
period. Mean pulmonary arterial pressure increased from
18±4 to 25±5mmHg (P<0.001) after the onset of ALI
and remained unchanged thereafter.
Discussion
The purpose of the present study was to determine the
effect of time on the improvement in arterial oxygenation
observed during PLV with four different doses of perfluo-
rocarbon in an experimental model of ALI in pigs. The
major finding was a time-dependent decrease in PaO2
during PLV with perfluorocarbon doses approximating the
functional residual capacity of the animals [1]. This may
indicate that, after initial deoxygenation of FC 3280, diffu-
sion of the respiratory gases through the perfluorocarbon
that pooled in the dependent unventilated or only poorly
ventilated lung segments was not sufficient to maintain
PaO2 values achieved immediately after instillation of the
liquid. Additionally, the continuous administration of perflu-
orocarbon in order to substitute for evaporational losses
Figure 1
Time-dependency of arterial oxygen tension (PaO2) during partial liquid
ventilation (PLV). Changes in PaO2 during PLV with four different doses
of the perfluorocarbon FC 3280 (7.5, 15, 22.5 and 30 ml/kg). Baseline
denotes measurements of PaO2 in the healthy, anaesthetized animals;
acute lung injury (ALI) denotes values after the induction of lung injury;
5 and 30 min denote determination of PaO2 after 5 and 30 min PLV
with each dose of perfluorocarbon. *P < 0.05 versus ALI, #P < 0.05
versus values after 5 min with the same dose of perfluorocarbon.
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.can avoid a decrease in the total volume of perfluorocar-
bon in the lung, but there may be a significant difference in
the distribution of the liquid when compared with the
application of a bolus. Evaporation is likely to be increased
in lung units reconducted to gaseous ventilation after
recruitment due to the surfactant-like activity of perfluoro-
carbon. If the evaporational loss of perfluorocarbon in
these units can not be substituted due to their localization,
the alveoli may destabilize again and recurrent atelectasis
may occur, resulting in a time-dependent decrease in arte-
rial oxygenation.
The model we used in the present investigation was eval-
uated before [10] and has been shown to be stable,
even over extended periods [12]. It has been extensively
used in other experimental studies on the effect of PLV
on pulmonary gas exchange and lung mechanics
[6,12–14]. Although the early stage of the lung injury
generated in this model resembles more the neonatal
form of the respiratory distress syndrome, its late stage
demonstrates all features of severe ARDS such as
atelectasis, increased alveolar permeability and desqua-
mation of airway epithelium [15]. The observation of the
present study that PLV can improve gas exchange and
peak airway pressure in the saline lung lavage model is
in accordance with the results of other investigators.
Also, physical or chemical differences between Perflu-
bron (Liquivent; Alliance, San Diego, USA), recently
under investigation in human trials, and FC 3280 used in
the present study are unlikely to influence these effects,
as previously shown by our group [11]. In contrast to
these experimental findings, the first studies on humans
with ARDS reported a more inhomogenous response to
PLV. Hirschl et al [16] applied PLV to patients with acute
respiratory distress on extracorporeal life support and
found that some patients did not demonstrate improve-
ments in pulmonary right-to-left shunt and arterial oxy-
genation after the endotracheal instillation of
perfluorocarbon. Furthermore, a clinical study investigat-
ing the effect of PLV in premature infants with severe
respiratory distress syndrome [3] also reported a wide
range of individual responses. The reason for this lack of
effect remains speculative, but it may be assumed that
different degrees and causes of lung injury determining
ventilation may account for this observation.
The transfer of oxygen from the inspired gas to the erythro-
cyte depends on several components such as the number
of ventilated alveoli, the diameter of the airway, the thick-
ness of the alveolar–capillary membrane and the capillary
transit time as a function of cardiac output [17]. These vari-
ables are seriously affected in ARDS due to the increased
weight of the infiltrated lung, which results in airway col-
lapse and increased density preferentially in the dependent
lung segments [18] and a severe reduction in the ventilated
lung volume with a subsequent increase in pulmonary shunt
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[19,20]. The application of a gaseous PEEP in patients with
ARDS has been shown to recruit atelectatic lung segments,
thereby increasing the volume of lung accessible for ventila-
tion and improving gas exchange [20]. Consequently, the
instillation of perfluorocarbon has been proposed to act like
a liquid PEEP, exerting its vertically graded, beneficial effect
of distending collapsed lung regions preferentially in the
dependent lung areas due to the high density of the perfluo-
rocarbons [21]. However, despite the recruitment of
atelectatic alveoli, the pooling of perfluorocarbon in the
dependent lung segments have been shown [7] to reduce
or avoid gaseous ventilation in these areas, possibly impair-
ing gas exchange unless a sufficient gas transfer over the
liquid column can be achieved. Whether such a transfer
through the perfluorocarbon actually occurs is still unclear
[21]. Like during the instillation of the liquid, when the
intense contact with the respiratory gas is assumed to result
in complete oxygenation of the perfluorocarbon, it may
depend on the existence of the postulated intrapulmonary in
vivo bubble oxygenation and the contact surface between
the inspiratory gas and the perfluorocarbon in comparison
with the alveolar surface persistently covered by the liquid.
Furthermore, the uptake of oxygen by the erythrocyte has to
be equalled by its transfer from the gaseous tidal volume to
the perfluorocarbon. Both determinants are still unknown.
However, our observation that arterial oxygenation demon-
strates a time-dependent decrease may indicate that this
mechanism could be of inferior importance in maintaining
gas exchange during PLV and that the redistribution of
blood flow and the recruitment of alveoli that remain venti-
lated thereafter predominantly account for the improvement
in PaO2. This conclusion is supported by data from Mates
et al [9] who found a dose-dependent increase in pul-
monary shunt during PLV in healthy piglets using the multi-
ple inert gas elimination technique. They suggest that, apart
from pure shunt, these results are due to a diffusion limita-
tion of oxygen and carbon dioxide in lungs partly filled with
perfluorocarbon.
These uncertainties need to be addressed in future
studies investigating the ventilation:perfusion ratio and the
diffusion of gases through the liquid perfluorocarbons, in
order to understand better the mechanisms by which PLV
can improve gas exchange and to elucidate the relevance
of the compound as a transfer medium for oxygen and
carbon dioxide during PLV.
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